Mr. Glenn has served as the company's President since December 2008.  He has more than 25 years of industry experience with companies such as Allergan, Elan/Athena and Cell Pathways.  Lloyd has been involved in the rare disease community for more than 15 years with the development and commercialization of products such as Botox, Permax, Zanaflex, Diastat and Acthar Gel.  In addition, he has worked closely with various rare disease patient advocacy groups and is a past member of the Board of Directors of the National Organization for Rare Disorders (NORD).


Matthias Kurth, MD, PhD - Vice President of Medical and Regulatory Affairs

Dr. Kurth has served as the company's Vice President of Medical and Regulatory Affairs since August 2009.  Matt has more than 12 years of pharmaceutical industry experience with companies such as Axys Pharmaceuticals, Questcor Pharmaceuticals, Neurogen and Allergan.  The breadth of his past experience includes responsibility for all aspects of clinical drug development as well as heading up Medical, Regulatory and Quality Assurance departments.  Dr. Kurth is a board certified neurologist with a particular focus on movement disorders such as Parkinson's disease.